Shortcomings of "FIB-4 First" strategy in screening for nonalcoholic fatty liver disease (NAFLD) patients at risk for disease progression in a real life setting: will we be detracting therapeutic opportunities from patients?

JOURNAL OF HEPATOLOGY(2023)

引用 0|浏览12
暂无评分
关键词
screening,liver,disease progression,nafld,non-alcoholic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要